+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lateral Flow Immunoassay Based Rapid Test Market by Application Type Technique type and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 4989494
  • Report
  • November 2019
  • Region: Global
  • 393 pages
  • Allied Analytics LLP
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Becton
  • Biomerieux SA
  • Bio-rad Laboratories Inc.
  • Dickinson and Company
  • Hologic Inc.
  • Qiagen N.V.
  • MORE
The global LFIA based rapid test market was valued at $4,725 million in 2018, and is projected to reach $8,494 million by 2026, registering a CAGR of 7.6% from 2019 to 2026. Lateral flow tests, or lateral flow immunochromatographic assays, are simple cellulose-based medical devices used to detect the presence of a target analyte in sample without use of specialized equipment where preliminary screening tests need to be conducted. These tests are incorporated in diagnosis of different diseases and health conditions such as HIV, influenza, malaria, pregnancy & fertility, drug screening, and others.

It is estimated that LFIA based rapid test market is expected to experience significant market growth during the forecast period as these tests are easy to perform, quick, and provide specific results; hence, are used in settings with limited resources. In addition, increased promotional activities by manufacturers encourage the usage these tests, which further facilitate the growth of the market. However, stringent government regulations for the approval of rapid tests and recall of several products due to false results are expected to impede the market growth. Moreover, increase in awareness regarding early diagnosis of disease, surge in initiatives by the government agencies, increase in incidence of infectious diseases, and need for low cost as well as accurate diagnostic testing are further supports the market growth.

The global rapid tests market is segmented into application, technique, end user, and region. The applications covered in the study include, infectious disease, pregnancy & fertility, toxicology, and others. Depending on techniques, the market is classified into competitive assay, sandwich assay, and multiplex detection assay. The infectious disease segment is further influenza, mosquito-borne diseases, HIV, hepatitis, and others. In addition, Dengue, chikungunya, malaria, and others are covered under mosquito-borne diseases. According to end user, the market is segmented as hospital & clinic, diagnostic laboratory, home care, and others. By region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, Philippines, Vietnam, Malaysia, Thailand, Singapore, Indonesia, Myanmar, Sri Lanka, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS

By Application
  • Infectious disease
  • Influenza
  • Mosquito-borne diseases
  • Dengue
  • Chikungunya
  • Malaria
  • Others
  • HIV
  • Hepatitis
  • Others
  • Pregnancy & fertility
  • Toxicology
  • Others
By Technique type
  • Competitive assay
  • Sandwich assay
  • Multiplex detection assay
By End User
  • Hospital & clinic
  • Diagnostic laboratory
  • Home care
  • Others
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Vietnam
  • Malaysia
  • Thailand
  • Singapore
  • Indonesia
  • Myanmar
  • Sri Lanka
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Abbott Laboratories (Alere Inc.)
  • Becton, Dickinson and Company
  • Bio-rad Laboratories, Inc.
  • Danaher Corporation (Cepheid, Inc.)
  • Hologic, Inc.
  • Quidel Corporation
  • F. Hoffmann-La Roche AG (Roche Diagnostics)
  • BIOMERIEUX SA
  • QIAGEN N.V.
  • Thermo Fisher Scientific
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Abingdon Health
  • ARKRAY, Inc.
  • Biocom Diagnostics
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Becton
  • Biomerieux SA
  • Bio-rad Laboratories Inc.
  • Dickinson and Company
  • Hologic Inc.
  • Qiagen N.V.
  • MORE
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List Of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary
2.1. Key Findings Of The Study
2.1.1. CXO Perspective

Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Market Player Positioning, 2018
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Benefits Of Lfia Based Rapid Tests Over Laboratory Testing
3.3.1.2. Increase In Initiatives Of Government And Nonprofit Organizations Towards Health Awareness
3.3.1.3. Increase In Healthcare Expenditure Worldwide
3.3.2. Restraint
3.3.2.1. Inadequate Reimbursement Policies For Lfia Based Rapid Test Diagnostics
3.3.3. Opportunities
3.3.3.1. Growth Opportunities In The Emerging Markets
3.3.3.2. Increase In Prevalence Of Various Chronic And Infectious Diseases Across The World
3.3.4. Impact Analysis

Chapter 4: Lfia Based Rapid Test Market, By Application
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Infectious Disease
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Type
4.2.2.1. Influenza
4.2.2.2. Mosquito-Borne
4.2.2.2.1. Mosquito-Borne Diseases Market Size And Forecast, By Type
4.2.2.2.2. Dengue
4.2.2.2.2.1. Dengue Diseases Market Size
4.2.2.2.3. Chikungunya
4.2.2.2.3.1. Chikungunya Diseases Market Size
4.2.2.2.4. Malaria
4.2.2.2.4.1. Malaria Diseases Market Size
4.2.2.2.5. Others
4.2.2.2.5.1. Others Diseases Market Size
4.2.2.3. Hiv
4.2.2.4. Hepatitis
4.2.2.5. Others
4.2.3. Market Size And Forecast, By Region
4.2.4. Market Analysis, By Country
4.3. Pregnancy & Fertility
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Toxicology
4.4.1. Key Market Trends, Growth Factors, And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
4.5. Others
4.5.1. Key Market Trends, Growth Factors, And Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis, By Country

Chapter 5: Lfia Based Rapid Test Market, By Technique Type
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Competitive Assay Lfia Based Rapid Test
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
5.3. Sandwich Assay Lfia Based Rapid Test
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
5.4. Multiplex Detection Assay Lfia Based Rapid Test
5.4.1. Arket Size And Forecast, By Region
5.4.2. Market Analysis, By Country

Chapter 6: Lfia Based Rapid Test Market, By End User
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Hospital & Clinic
6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country
6.3. Diagnostic Laboratory
6.3.1. Market Size And Forecast
6.3.2. Market Analysis, By Country
6.4. Home Care
6.4.1. Market Size And Forecast
6.4.2. Market Analysis, By Country
6.5. Others
6.5.1. Market Size And Forecast
6.5.2. Market Analysis, By Country

Chapter 7: Lfia Based Rapid Test Market By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Lfia Based Rapid Test Market, By Application
7.2.2.1.2. U.S. Lfia Based Rapid Test Market, By Technique Type
7.2.2.1.3. U.S. Lfia Based Rapid Test Market, By End User
7.2.2.2. Canada
7.2.2.2.1. Canada Lfia Based Rapid Test Market, By Application
7.2.2.2.2. Canada Lfia Based Rapid Test Market, By Technique Type
7.2.2.2.3. Canada Lfia Based Rapid Test Market, By End User
7.2.2.3. Mexico
7.2.2.3.1. Mexico Lfia Based Rapid Test Market, By Application
7.2.2.3.2. Mexico Lfia Based Rapid Test Market, By Technique Type
7.2.2.3.3. Mexico Lfia Based Rapid Test Market, By End User
7.2.3. North America Lfia Based Rapid Test Market, By Application
7.2.4. North America Lfia Based Rapid Test Market, By Technique Type
7.2.5. North America Lfia Based Rapid Test Market, By End User
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Lfia Based Rapid Test Market, By Application
7.3.2.1.2. Germany Lfia Based Rapid Test Market, By Technique Type
7.3.2.1.3. Germany Lfia Based Rapid Test Market, By End User
7.3.2.2. France
7.3.2.2.1. France Lfia Based Rapid Test Market, By Application
7.3.2.2.2. France Lfia Based Rapid Test Market, By Technique Type
7.3.2.2.3. France Lfia Based Rapid Test Market, By End User
7.3.2.3. UK
7.3.2.3.1. UK Lfia Based Rapid Test Market, By Application
7.3.2.3.2. UK Lfia Based Rapid Test Market, By Technique Type
7.3.2.3.3. UK Lfia Based Rapid Test Market, By End User
7.3.2.4. Italy
7.3.2.4.1. Italy Lfia Based Rapid Test Market, By Application
7.3.2.4.2. Italy Lfia Based Rapid Test Market, By Technique Type
7.3.2.4.3. Italy Lfia Based Rapid Test Market, By End User
7.3.2.5. Spain
7.3.2.5.1. Spain Lfia Based Rapid Test Market, By Application
7.3.2.5.2. Spain Lfia Based Rapid Test Market, By Technique Type
7.3.2.5.3. Spain Lfia Based Rapid Test Market, By End User
7.3.2.6. Rest Of Europe
7.3.2.6.1. Rest Of Europe Lfia Based Rapid Test Market, By Application
7.3.2.6.2. Rest Of Europe Lfia Based Rapid Test Market, By Technique Type
7.3.2.6.3. Rest Of Europe Lfia Based Rapid Test Market, By End User
7.3.3. Europe Lfia Based Rapid Test Market, By Application
7.3.4. Europe Lfia Based Rapid Test Market, By Technique Type
7.3.5. Europe Lfia Based Rapid Test Market, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Lfia Based Rapid Test Market, By Application
7.4.2.1.2. Japan Lfia Based Rapid Test Market, By Technique Type
7.4.2.1.3. Japan Lfia Based Rapid Test Market, By End User
7.4.2.2. China
7.4.2.2.1. China Lfia Based Rapid Test Market, By Application
7.4.2.2.2. China Lfia Based Rapid Test Market, By Technique Type
7.4.2.2.3. China Lfia Based Rapid Test Market, By End User
7.4.2.3. Australia
7.4.2.3.1. Australia Lfia Based Rapid Test Market, By Application
7.4.2.3.2. Australia Lfia Based Rapid Test Market, By Technique Type
7.4.2.3.3. Australia Lfia Based Rapid Test Market, By End User
7.4.2.4. India
7.4.2.4.1. India Lfia Based Rapid Test Market, By Application
7.4.2.4.2. India Lfia Based Rapid Test Market, By Technique Type
7.4.2.4.3. India Lfia Based Rapid Test Market, By End User
7.4.2.5. Philippines
7.4.2.5.1. Philippines Lfia Based Rapid Test Market, By Application
7.4.2.5.2. Philippines Lfia Based Rapid Test Market, By Technique Type
7.4.2.5.3. Philippines Lfia Based Rapid Test Market, By End User
7.4.2.6. Vietnam
7.4.2.6.1. Vietnam Lfia Based Rapid Test Market, By Application
7.4.2.6.2. Vietnam Lfia Based Rapid Test Market, By Technique Type
7.4.2.6.3. Vietnam Lfia Based Rapid Test Market, By End User
7.4.2.7. Malaysia
7.4.2.7.1. Malaysia Lfia Based Rapid Test Market, By Application
7.4.2.7.2. Malaysia Lfia Based Rapid Test Market, By Technique Type
7.4.2.7.3. Malaysia Lfia Based Rapid Test Market, By End User
7.4.2.8. Thailand
7.4.2.8.1. Thailand Lfia Based Rapid Test Market, By Application
7.4.2.8.2. Thailand Lfia Based Rapid Test Market, By Technique Type
7.4.2.8.3. Thailand Lfia Based Rapid Test Market, By End User
7.4.2.9. Singapore
7.4.2.9.1. Singapore Lfia Based Rapid Test Market, By Application
7.4.2.9.2. Singapore Lfia Based Rapid Test Market, By Technique Type
7.4.2.9.3. Singapore Lfia Based Rapid Test Market, By End User
7.4.2.10. Indonesia
7.4.2.10.1. Indonesia Lfia Based Rapid Test Market, By Application
7.4.2.10.2. Indonesia Lfia Based Rapid Test Market, By Technique Type
7.4.2.10.3. Indonesia Lfia Based Rapid Test Market, By End User
7.4.2.11. Myanmar
7.4.2.11.1. Myanmar Lfia Based Rapid Test Market, By Application
7.4.2.11.2. Myanmar Lfia Based Rapid Test Market, By Technique Type
7.4.2.11.3. Myanmar Lfia Based Rapid Test Market, By End User
7.4.2.12. Sri Lanka
7.4.2.12.1. Sri Lanka Lfia Based Rapid Test Market, By Application
7.4.2.12.2. Sri Lanka Lfia Based Rapid Test Market, By Technique Type
7.4.2.12.3. Sri Lanka Lfia Based Rapid Test Market, By End User
7.4.2.13. Rest Of Asia-Pacific
7.4.2.13.1. Rest Of Asia-Pacific Lfia Based Rapid Test Market, By Application
7.4.2.13.2. Rest Of Asia-Pacific Lfia Based Rapid Test Market, By Technique Type
7.4.2.13.3. Rest Of Asia-Pacific Lfia Based Rapid Test Market, By End User
7.4.3. Asia-Pacific Lfia Based Rapid Test Market, By Application
7.4.4. Asia-Pacific Lfia Based Rapid Test Market, By Technique Type
7.4.5. Asia-Pacific Lfia Based Rapid Test Market, By End User
7.5. LAMEA
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.2.1. Brazil
7.5.2.1.1. Japan Lfia Based Rapid Test Market, By Application
7.5.2.1.2. Brazil Lfia Based Rapid Test Market, By Technique Type
7.5.2.1.3. Brazil Lfia Based Rapid Test Market, By End User
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia Lfia Based Rapid Test Market, By Application
7.5.2.2.2. Saudi Arabia Lfia Based Rapid Test Market, By Technique Type
7.5.2.2.3. Saudi Arabia Lfia Based Rapid Test Market, By End User
7.5.2.3. South Africa
7.5.2.3.1. South Africa Lfia Based Rapid Test Market, By Application
7.5.2.3.2. South Africa Lfia Based Rapid Test Market, By Technique Type
7.5.2.3.3. South Africa Lfia Based Rapid Test Market, By End User
7.5.2.4. Rest Of LAMEA
7.5.2.4.1. Rest Of LAMEA Lfia Based Rapid Test Market, By Application
7.5.2.4.2. Rest Of LAMEA Lfia Based Rapid Test Market, By Technique Type
7.5.2.4.3. Rest Of LAMEA Lfia Based Rapid Test Market, By End User
7.5.3. LAMEA Lfia Based Rapid Test Market, By Application
7.5.4. LAMEA Lfia Based Rapid Test Market, By Technique Type
7.5.5. LAMEA Lfia Based Rapid Test Market, By End User

Chapter 8: Competitive Landscape
8.1. Introduction
8.2. Competitive Dashboard
8.3. Competitive Heatmap

Chapter 9: Company Profiles
9.1. Abbott Laboratories (Alere Inc.)
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.1.6. Key Strategic Moves And Developments
9.2. Becton Dickinson And Company
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Business Performance
9.3. Biomerieux Sa
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.3.5. Business Performance
9.4. Bio-Rad Laboratories, Inc.
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Business Performance
9.5. Danaher Corporation (Cepheid, Inc.)
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.5.5. Business Performance
9.5.6. Key Strategic Moves And Developments
9.6. F. Hoffmann-La Roche Ag (Roche Diagnostics)
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Business Performance
9.7. Hologic, Inc.
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.8. Qiagen N.V.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.8.5. Business Performance
9.9. Quidel Corporation
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.9.5. Business Performance
9.10. Thermo Fisher Scientific
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
9.10.5. Business Performance

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Becton
  • Biomerieux SA
  • Bio-rad Laboratories Inc.
  • Dickinson and Company
  • Hologic Inc.
  • Qiagen N.V.
  • MORE
According to the report titled, 'LFIA Based Rapid Test Market, by Application, Techniques, End User: Global Opportunity Analysis and Industry Forecast, 2019-2026', the global LFIA based rapid test market size was valued at $4.72 billion in 2018, and is expected to reach $8.50 billion by 2026, growing at a CAGR of 7.6% from 2019 to 2026.

LFIA based rapid test market is anticipated to exhibit growth owing to increase in incidence of infectious disease, rise in awareness about these tests owing in developing countries, surge in promotional activities by the key players, no need of complex medical devices, and lower cost of the tests. In addition, other factors, such as speed of diagnosis, convenience, specificity, and stability further support the lateral flow immunoassay based rapid test market growth.

At present, by application, the pregnancy & fertility and infectious disease segment is the highest revenue contributor, and is anticipated to remain dominant in the near future. Moreover, easy availability of cost-efficient products, rise in promotion activities by the key players for LFIA based rapid test, and increase in adoption of LFIA based rapid test among the general population fuel the growth of this segment. However, infectious disease segment is expected to exhibit the fastest market growth during the forecast period due to surge in incidence of infectious disease and rise in demand for low cost & accurate rapid tests for preliminary infectious disease testing.

By end user, the home care segment occupied the largest share in 2018, and is anticipated to continue its dominance during the forecast period, due to increased demand for personalized care rapid tests and cost-efficient product availability.

Key Findings of the LFIA Based Rapid Test Market:
As per the application, the infectious disease segment is expected to exhibit the fastest growth, registering a CAGR of 7.8% from 2019 to 2026, in terms of value.
On the basis of the technique type, the multiplex detection assay segment is expected to exhibit the fastest growth, registering a CAGR of 8.9% from 2019 to 2026, in terms of value.
By end user, the hospitals & Clinics segment is expected to grow at the highest CAGR of 11.6% from 2019 to 2026, in terms of value.
Region wise, Asia-Pacific is expected to witness the highest growth rate, registering a CAGR of 10.6% during the forecast period, in terms of volume.
North America accounted approximately one-half of the global market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the well-developed healthcare infrastructure, higher awareness about advanced applications of rapid tests among the healthcare professionals & patients, and ease of product availability. On the other side, Asia-Pacific is projected to grow at the highest CAGR during the forecast period, owing to increase in demand for LFIA based rapid tests; upsurge in incidence of infectious disease, rise in drug screening procedures; and surge in use of home care diagnostics devices.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories (Alere Inc.)
  • Becton
  • Dickinson and Company
  • Bio-rad Laboratories Inc.
  • Danaher Corporation (Cepheid Inc.)
  • Hologic Inc.
  • Quidel Corporation
  • F. Hoffmann-La Roche AG (Roche Diagnostics)
  • Biomerieux SA
  • Qiagen N.V.
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll